Breakthrough Fungal Infections in Patients With Leukemia Receiving Isavuconazole.

ABSTRACT: We retrospectively assessed breakthrough invasive fungal infections (b-IFIs) in 100 consecutive patients with leukemia receiving single-agent isavuconazole; 13 had documented b-IFIs (candidiasis in 6, mucormycosis in 4). All b-IFIs were observed in patients with prolonged neutropenia and active leukemia.

SUBMITTER: Rausch CR 

PROVIDER: S-EPMC6454429 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature